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I deeply appreciate the comments of Dr. Bo Kyung Koo on our 
study “Prevalence of dyslipidemia among Korean adults: Ko-
rea National Health and Nutrition Survey 1998-2005” which 
was published in Diabetes & Metabolism Journal 2012;36:43-55. 
Metabolic syndrome is a cluster of multiple cardiometabolic 
risk factors, and prevalence of the syndrome is expected to in-
crease in Korea [1,2]. However, as Dr. Koo noted, common 
definitions of metabolic syndrome do not include elevated low 
density lipoprotein cholesterol (LDL-C) level, which is strong-
ly associated with atherosclerotic cardiovascular disease [3,4]. 
Dr. Koo also mentioned that evaluation of lipid abnormalities 
can provide additional predictive value compared to the pres-
ence of metabolic syndrome. This is an important comment 
and the reason why we reported prevalence of different forms 
of dyslipidemia including elevated total cholesterol, elevated 
triglycerides, elevated LDL-C, and reduced high density lipo-
protein cholesterol (HDL-C).
  Dr. Koo raised an epidemiologically and clinically relevant 
issue regarding the definition of low HDL-C level. In defining 
metabolic syndrome, the cutoff level of low HDL-C is frequent-
ly higher for women because women have a higher HDL-C 
distribution compared to men. According to the definition of 
metabolic syndrome in the NCEP-ATP III guidelines, reduced 
HDL-C level is defined as <50 mg/dL in women and <40 mg/
dL in men [3]. However, the NCEP-ATP III criteria for reduced 
HDL-C might not be appropriate for the Korean population. 
Compared to the Western population, East Asian populations 
have lower HDL-C level and show smaller sex differences for 
this measure. Moreover, HDL-C levels among Koreans are 
even lower than those of other East Asian populations and 
show only a small sex difference [5-8]. In our study, the sex 
difference in mean HDL-C (women minus men) was only 2.1 
mg/dL in 1998, 3.6 mg/dL in 2001, and 5.0 mg/dL in 2005 [9]. 
Because Korean women have relatively low HDL-C levels, 
58.5% of women had an HDL-C level lower than 50 mg/dL in 
the 2001 KNHANES [10]. This caused the unusually high 
prevalence of metabolic syndrome, in comparison to the low 
prevalence of obesity, among Korean women in the literature. 
We also lack direct data regarding the level of HDL-C that 
should be treated. It is unclear whether women with HDL-C 
level of 40 to 49 mg/dL but without other lipid abnormalities 
should be treated. For these reasons, some Asian studies have 
used a cutoff for reduced HDL-C of <40 mg/dL for both sexes 
[6,11].
  Overall, I appreciate and agree with Dr. Koo’s considerate 
comments. Great attention should be given to the working 
definitions when reporting and interpreting prevalence of 
metabolic syndrome and dyslipidemia. Further studies are also 
required to establish an appropriate definition of dyslipidemia 
in the Korean population.
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